Understanding Patients’ Journeys Prior to Initiating Calcitonin Gene-related Peptide Monoclonal Antibody for Migraine Prevention in the United States

Treatment with Eptinezumab Reduces Brain Fog and Increases the Number of Good Days Per Month in Patients with Chronic Migraine in a Real-world Setting

A Headache for a Headache: Variability in Prior Authorizations as a Bottleneck for Patient Access to CGRP-modulating Medications to Treat Migraine